| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |